Streetbeat News

Products Services

OCUL

Ocular Therapeutix has received a written response from the FDA indicating that the Phase 3 Sol-r trial is appropriate for use as the company's second adequate and well-controlled study of Axpaxli (Axitinib Intravitreal Implant, also known as OTX-TKI) for wet age-related macular degeneration.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:10 am

SONY

Sony Group Corp (NYSE: SONY) reported strong fiscal Q1 2024 results, with sales and earnings beating analyst estimates. Key growth drivers were the Music and Gaming divisions. Despite a miss in PS5 unit sales, the company raised its fiscal 2024 sales outlook.

Portfolio Pulse from Anusuya Lahiri

August 07, 2024 | 11:06 am

DIA

QQQ

SPY

USO

UUP

U.S. stock markets closed higher on Tuesday, driven by Federal Reserve officials' comments easing recession fears. The S&P 500 and Nasdaq saw gains, with all major sectors in the S&P 500 closing higher. The Dow Jones Industrial Average also rose. In economic data, the U.S. trade deficit narrowed in June. Asian markets, particularly Japan's Nikkei 225, saw significant gains, while European markets also experienced growth. Crude oil and the U.S. dollar advanced, with the U.S. dollar index gaining 0.31%.

Portfolio Pulse from Akanksha Bakshi

August 07, 2024 | 10:59 am

GO

Grocery Outlet shares are trading higher following the release of better-than-expected Q2 financial results. The company also announced plans to open 62-64 new stores in FY24.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:53 am

DIS

Disney announced that it remains on track for profitability in its combined streaming businesses, with both Entertainment DTC and ESPN+ expected to be profitable in Q4.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:52 am

DIS

Disney expects modest growth in Disney+ core subscribers in Q4, indicating a steady but slow increase in its streaming service user base.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:52 am

TAK

The European Commission has approved Takeda's Adzynma for the treatment of ADAMTS13 deficiency in both children and adults with congenital thrombotic thrombocytopenic purpura (cTTP).

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:51 am

ZBH

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has announced the acquisition of OrthoGrid Systems, Inc., a company specializing in AI-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrid's Hip AI® platform, two FDA-cleared applications, and over 40 patents.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:34 am

AL

BA

Air Lease Corporation (AL) announced the delivery of a new Boeing 787-10 to Korean Air. This is the first of ten 787-10s that Air Lease will deliver to Korean Air from its orderbook with Boeing (BA).

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 10:33 am

LLY

NVO

Novo Nordisk's shares fell 3% in pre-market trading after missing Q2 profit expectations and revising its operating profit outlook downwards. Despite raising sales growth expectations for 2024, the company faces competition from Eli Lilly's weight loss drug, Zepbound.

Portfolio Pulse from Benzinga Neuro

August 07, 2024 | 10:26 am